Artificial Pancreas Devices Systems Market By Device Type (Threshold Suspend Device Systems, Control-To-Range (CTR) Systems, Control-To-Target (CTT) Systems) , By End User (Hospitals, Clinics, Homecare) : Global Opportunity Analysis and Industry Forecast, 2024-2033
The artificial pancreas devices systems market was valued at $0.4 billion in 2023, and is projected t%li%reach $0.8 billion by 2033, growing at a CAGR of 8.8% from 2024 t%li%2033.
Artificial pancreas device is a medical device that mimics the glucose-regulating function of a healthy pancreas, aiming t%li%maintain optimal blood sugar levels. This medical technology is primarily designed t%li%monitor and regulate blood glucose levels in individuals suffering from diabetes, particularly those with type 1 diabetes. These devices aim t%li%restore lost functions, enhance human capabilities, and improve overall quality of life.
The growth of the artificial pancreas devices systems market is majorly driven by alarming increase in global prevalence of diabetes, particularly type 1 diabetes and rise in awareness among patients and healthcare providers about the benefits of artificial pancreas systems. According t%li%the 2021 key findings of IDF Diabetes Atlas 10th edition, approximately 537 million adults are suffering diabetes. This number is estimated t%li%reach 643 million by 2030 and 783 million by 2045. Around 6.7 million deaths were reported due t%li%diabetes in 2021. Moreover, increase in healthcare expenditure, particularly in emerging economies, allows more patients t%li%access advanced diabetes management technologies. As per the same source, diabetes was responsible for at least $966 billion dollars in health expenditure in 2021. Furthermore, the integration of artificial pancreas devices systems with digital health platforms and smartphone applications enhances patient engagement and allows for better remote monitoring and management, which acts as the key driving force of the market. However, high cost associated with the artificial pancreas devices systems restrains the growth of the market. Moreover, lack of appropriate health facilities t%li%meet population needs in most countries and limited access act as the key deterrent factors of the market. On the contrary, continuous improvements in sensor technology, insulin delivery systems, and control algorithms enhance the performance and reliability of artificial pancreas systems, which are expected t%li%offer remunerative opportunities for the expansion of the global market during the forecast period. In addition, increase in initiatives aimed at improving diabetes care and management are providing incentives for the adoption of artificial pancreas systems. For instance, the World Health Organization launched an initiative in April 2021, WHO Global Diabetes Compact. The initiative aims t%li%reduce the risk of diabetes and ensure that diabetic individuals have access t%li%affordable and quality treatment and care.
The artificial pancreas devices systems industry is segmented int%li%device type, end user, and region. By device type, the market is divided int%li%threshold suspend device systems, control-to-range (CTR) systems, and control-to-target (CTT) systems. On the basis of end user, it is divided int%li%hospitals, clinics, homecare. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By device type, the threshold suspend device systems segment dominated the market, in terms of share, in 2023.
Depending on end user, the homecare segment captured the largest share in 2023.
Region wise, North America holds a dominant position in the market in 2023.
Competition Analysis
Competitive analysis and profiles of the major players in the global artificial pancreas devices systems market include Medtronic plc, Bigfoot Biomedical, Inc., Johnson & Johnson, Tandem Diabetes Care, Inc., Pancreum, Inc, TypeZer%li%Technologies, LLC, Beta Bionics, Inc, Insulate Corporation, Diabeloop, and Inreda Diabetic. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships t%li%strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
By Device Type
Artificial pancreas device is a medical device that mimics the glucose-regulating function of a healthy pancreas, aiming t%li%maintain optimal blood sugar levels. This medical technology is primarily designed t%li%monitor and regulate blood glucose levels in individuals suffering from diabetes, particularly those with type 1 diabetes. These devices aim t%li%restore lost functions, enhance human capabilities, and improve overall quality of life.
The growth of the artificial pancreas devices systems market is majorly driven by alarming increase in global prevalence of diabetes, particularly type 1 diabetes and rise in awareness among patients and healthcare providers about the benefits of artificial pancreas systems. According t%li%the 2021 key findings of IDF Diabetes Atlas 10th edition, approximately 537 million adults are suffering diabetes. This number is estimated t%li%reach 643 million by 2030 and 783 million by 2045. Around 6.7 million deaths were reported due t%li%diabetes in 2021. Moreover, increase in healthcare expenditure, particularly in emerging economies, allows more patients t%li%access advanced diabetes management technologies. As per the same source, diabetes was responsible for at least $966 billion dollars in health expenditure in 2021. Furthermore, the integration of artificial pancreas devices systems with digital health platforms and smartphone applications enhances patient engagement and allows for better remote monitoring and management, which acts as the key driving force of the market. However, high cost associated with the artificial pancreas devices systems restrains the growth of the market. Moreover, lack of appropriate health facilities t%li%meet population needs in most countries and limited access act as the key deterrent factors of the market. On the contrary, continuous improvements in sensor technology, insulin delivery systems, and control algorithms enhance the performance and reliability of artificial pancreas systems, which are expected t%li%offer remunerative opportunities for the expansion of the global market during the forecast period. In addition, increase in initiatives aimed at improving diabetes care and management are providing incentives for the adoption of artificial pancreas systems. For instance, the World Health Organization launched an initiative in April 2021, WHO Global Diabetes Compact. The initiative aims t%li%reduce the risk of diabetes and ensure that diabetic individuals have access t%li%affordable and quality treatment and care.
The artificial pancreas devices systems industry is segmented int%li%device type, end user, and region. By device type, the market is divided int%li%threshold suspend device systems, control-to-range (CTR) systems, and control-to-target (CTT) systems. On the basis of end user, it is divided int%li%hospitals, clinics, homecare. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By device type, the threshold suspend device systems segment dominated the market, in terms of share, in 2023.
Depending on end user, the homecare segment captured the largest share in 2023.
Region wise, North America holds a dominant position in the market in 2023.
Competition Analysis
Competitive analysis and profiles of the major players in the global artificial pancreas devices systems market include Medtronic plc, Bigfoot Biomedical, Inc., Johnson & Johnson, Tandem Diabetes Care, Inc., Pancreum, Inc, TypeZer%li%Technologies, LLC, Beta Bionics, Inc, Insulate Corporation, Diabeloop, and Inreda Diabetic. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships t%li%strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting t%li%16 analyst hours t%li%solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent t%li%3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
- Regulatory Guidelines
- Additional company profiles with specific t%li%client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
By Device Type
- Threshold Suspend Device Systems
- Control-To-Range (CTR) Systems
- Control-To-Target (CTT) Systems
- Hospitals
- Clinics
- Homecare
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Medtronic plc
- Bigfoot Biomedical, Inc.
- Johnson & Johnson
- Tandem Diabetes Care, Inc.
- Pancreum, Inc
- TypeZer%li%Technologies, LLC
- Beta Bionics, Inc
- Insulate Corporation
- Diabeloop
- Inreda Diabetic
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: ASTAXANTHIN MARKET, BY SOURCE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Source
4.2. Natural
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Synthetic
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: ASTAXANTHIN MARKET, BY FORM
5.1. Market Overview
5.1.1 Market Size and Forecast, By Form
5.2. Dry
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Liquid
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: ASTAXANTHIN MARKET, BY APPLICATION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Application
6.2. Dietary Supplements
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Cosmetics
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Others
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: ASTAXANTHIN MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Source
7.2.3. Market Size and Forecast, By Form
7.2.4. Market Size and Forecast, By Application
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Astaxanthin Market
7.2.6.1. Market Size and Forecast, By Source
7.2.6.2. Market Size and Forecast, By Form
7.2.6.3. Market Size and Forecast, By Application
7.2.7. Canada Astaxanthin Market
7.2.7.1. Market Size and Forecast, By Source
7.2.7.2. Market Size and Forecast, By Form
7.2.7.3. Market Size and Forecast, By Application
7.2.8. Mexico Astaxanthin Market
7.2.8.1. Market Size and Forecast, By Source
7.2.8.2. Market Size and Forecast, By Form
7.2.8.3. Market Size and Forecast, By Application
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Source
7.3.3. Market Size and Forecast, By Form
7.3.4. Market Size and Forecast, By Application
7.3.5. Market Size and Forecast, By Country
7.3.6. France Astaxanthin Market
7.3.6.1. Market Size and Forecast, By Source
7.3.6.2. Market Size and Forecast, By Form
7.3.6.3. Market Size and Forecast, By Application
7.3.7. Germany Astaxanthin Market
7.3.7.1. Market Size and Forecast, By Source
7.3.7.2. Market Size and Forecast, By Form
7.3.7.3. Market Size and Forecast, By Application
7.3.8. Italy Astaxanthin Market
7.3.8.1. Market Size and Forecast, By Source
7.3.8.2. Market Size and Forecast, By Form
7.3.8.3. Market Size and Forecast, By Application
7.3.9. Spain Astaxanthin Market
7.3.9.1. Market Size and Forecast, By Source
7.3.9.2. Market Size and Forecast, By Form
7.3.9.3. Market Size and Forecast, By Application
7.3.10. UK Astaxanthin Market
7.3.10.1. Market Size and Forecast, By Source
7.3.10.2. Market Size and Forecast, By Form
7.3.10.3. Market Size and Forecast, By Application
7.3.11. Rest of Europe Astaxanthin Market
7.3.11.1. Market Size and Forecast, By Source
7.3.11.2. Market Size and Forecast, By Form
7.3.11.3. Market Size and Forecast, By Application
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Source
7.4.3. Market Size and Forecast, By Form
7.4.4. Market Size and Forecast, By Application
7.4.5. Market Size and Forecast, By Country
7.4.6. China Astaxanthin Market
7.4.6.1. Market Size and Forecast, By Source
7.4.6.2. Market Size and Forecast, By Form
7.4.6.3. Market Size and Forecast, By Application
7.4.7. Japan Astaxanthin Market
7.4.7.1. Market Size and Forecast, By Source
7.4.7.2. Market Size and Forecast, By Form
7.4.7.3. Market Size and Forecast, By Application
7.4.8. India Astaxanthin Market
7.4.8.1. Market Size and Forecast, By Source
7.4.8.2. Market Size and Forecast, By Form
7.4.8.3. Market Size and Forecast, By Application
7.4.9. South Korea Astaxanthin Market
7.4.9.1. Market Size and Forecast, By Source
7.4.9.2. Market Size and Forecast, By Form
7.4.9.3. Market Size and Forecast, By Application
7.4.10. Australia Astaxanthin Market
7.4.10.1. Market Size and Forecast, By Source
7.4.10.2. Market Size and Forecast, By Form
7.4.10.3. Market Size and Forecast, By Application
7.4.11. Rest of Asia-Pacific Astaxanthin Market
7.4.11.1. Market Size and Forecast, By Source
7.4.11.2. Market Size and Forecast, By Form
7.4.11.3. Market Size and Forecast, By Application
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Source
7.5.3. Market Size and Forecast, By Form
7.5.4. Market Size and Forecast, By Application
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Astaxanthin Market
7.5.6.1. Market Size and Forecast, By Source
7.5.6.2. Market Size and Forecast, By Form
7.5.6.3. Market Size and Forecast, By Application
7.5.7. South Africa Astaxanthin Market
7.5.7.1. Market Size and Forecast, By Source
7.5.7.2. Market Size and Forecast, By Form
7.5.7.3. Market Size and Forecast, By Application
7.5.8. Saudi Arabia Astaxanthin Market
7.5.8.1. Market Size and Forecast, By Source
7.5.8.2. Market Size and Forecast, By Form
7.5.8.3. Market Size and Forecast, By Application
7.5.9. Rest of LAMEA Astaxanthin Market
7.5.9.1. Market Size and Forecast, By Source
7.5.9.2. Market Size and Forecast, By Form
7.5.9.3. Market Size and Forecast, By Application
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. INNOBIO Limited
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Divis Laboratories Limited
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Algaecan Biotech
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. ALGA Technologies
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Cyanotech Corporation.
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Otsuka Pharmaceutical Co.
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Cardax
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Fenchem
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. BGG
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Fuji Chemical Industries Company Limited
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: ASTAXANTHIN MARKET, BY SOURCE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Source
4.2. Natural
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Synthetic
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: ASTAXANTHIN MARKET, BY FORM
5.1. Market Overview
5.1.1 Market Size and Forecast, By Form
5.2. Dry
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Liquid
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: ASTAXANTHIN MARKET, BY APPLICATION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Application
6.2. Dietary Supplements
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Cosmetics
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Others
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: ASTAXANTHIN MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Source
7.2.3. Market Size and Forecast, By Form
7.2.4. Market Size and Forecast, By Application
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Astaxanthin Market
7.2.6.1. Market Size and Forecast, By Source
7.2.6.2. Market Size and Forecast, By Form
7.2.6.3. Market Size and Forecast, By Application
7.2.7. Canada Astaxanthin Market
7.2.7.1. Market Size and Forecast, By Source
7.2.7.2. Market Size and Forecast, By Form
7.2.7.3. Market Size and Forecast, By Application
7.2.8. Mexico Astaxanthin Market
7.2.8.1. Market Size and Forecast, By Source
7.2.8.2. Market Size and Forecast, By Form
7.2.8.3. Market Size and Forecast, By Application
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Source
7.3.3. Market Size and Forecast, By Form
7.3.4. Market Size and Forecast, By Application
7.3.5. Market Size and Forecast, By Country
7.3.6. France Astaxanthin Market
7.3.6.1. Market Size and Forecast, By Source
7.3.6.2. Market Size and Forecast, By Form
7.3.6.3. Market Size and Forecast, By Application
7.3.7. Germany Astaxanthin Market
7.3.7.1. Market Size and Forecast, By Source
7.3.7.2. Market Size and Forecast, By Form
7.3.7.3. Market Size and Forecast, By Application
7.3.8. Italy Astaxanthin Market
7.3.8.1. Market Size and Forecast, By Source
7.3.8.2. Market Size and Forecast, By Form
7.3.8.3. Market Size and Forecast, By Application
7.3.9. Spain Astaxanthin Market
7.3.9.1. Market Size and Forecast, By Source
7.3.9.2. Market Size and Forecast, By Form
7.3.9.3. Market Size and Forecast, By Application
7.3.10. UK Astaxanthin Market
7.3.10.1. Market Size and Forecast, By Source
7.3.10.2. Market Size and Forecast, By Form
7.3.10.3. Market Size and Forecast, By Application
7.3.11. Rest of Europe Astaxanthin Market
7.3.11.1. Market Size and Forecast, By Source
7.3.11.2. Market Size and Forecast, By Form
7.3.11.3. Market Size and Forecast, By Application
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Source
7.4.3. Market Size and Forecast, By Form
7.4.4. Market Size and Forecast, By Application
7.4.5. Market Size and Forecast, By Country
7.4.6. China Astaxanthin Market
7.4.6.1. Market Size and Forecast, By Source
7.4.6.2. Market Size and Forecast, By Form
7.4.6.3. Market Size and Forecast, By Application
7.4.7. Japan Astaxanthin Market
7.4.7.1. Market Size and Forecast, By Source
7.4.7.2. Market Size and Forecast, By Form
7.4.7.3. Market Size and Forecast, By Application
7.4.8. India Astaxanthin Market
7.4.8.1. Market Size and Forecast, By Source
7.4.8.2. Market Size and Forecast, By Form
7.4.8.3. Market Size and Forecast, By Application
7.4.9. South Korea Astaxanthin Market
7.4.9.1. Market Size and Forecast, By Source
7.4.9.2. Market Size and Forecast, By Form
7.4.9.3. Market Size and Forecast, By Application
7.4.10. Australia Astaxanthin Market
7.4.10.1. Market Size and Forecast, By Source
7.4.10.2. Market Size and Forecast, By Form
7.4.10.3. Market Size and Forecast, By Application
7.4.11. Rest of Asia-Pacific Astaxanthin Market
7.4.11.1. Market Size and Forecast, By Source
7.4.11.2. Market Size and Forecast, By Form
7.4.11.3. Market Size and Forecast, By Application
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Source
7.5.3. Market Size and Forecast, By Form
7.5.4. Market Size and Forecast, By Application
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Astaxanthin Market
7.5.6.1. Market Size and Forecast, By Source
7.5.6.2. Market Size and Forecast, By Form
7.5.6.3. Market Size and Forecast, By Application
7.5.7. South Africa Astaxanthin Market
7.5.7.1. Market Size and Forecast, By Source
7.5.7.2. Market Size and Forecast, By Form
7.5.7.3. Market Size and Forecast, By Application
7.5.8. Saudi Arabia Astaxanthin Market
7.5.8.1. Market Size and Forecast, By Source
7.5.8.2. Market Size and Forecast, By Form
7.5.8.3. Market Size and Forecast, By Application
7.5.9. Rest of LAMEA Astaxanthin Market
7.5.9.1. Market Size and Forecast, By Source
7.5.9.2. Market Size and Forecast, By Form
7.5.9.3. Market Size and Forecast, By Application
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. INNOBIO Limited
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Divis Laboratories Limited
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Algaecan Biotech
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. ALGA Technologies
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Cyanotech Corporation.
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Otsuka Pharmaceutical Co.
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Cardax
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Fenchem
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. BGG
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Fuji Chemical Industries Company Limited
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
